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Editorial: Evaluation of Current HIV Contributions toward Progress 
in HIV management  
HIV infection is not merely a contagious disease, it is a multi-aspect heath related issue which needs local and 
global contributions in order to reach the targets in HIV management. The objective of this Special Issue in "Journal 
of Therapy and Management in HIV Infection" is to highlight the progress and evaluation of HIV related health 
issues.  
The articles presented in this issue address:  
1. To measure the prevalence of ARV side effects in pregnant women and their infants and also evaluate drug 
efficacy in decrease of child HIV infection, Jozani et al. conducted a study on information of 40 files of 
pregnant HIV positive women. Most common drugs used for HIV infection were assessed and multiple 
adverse effects were evaluated. Based on findings of this study, having observed the safety of ARV in 
pregnancy period and at birth especially in PMTCT group, ARV treatment or PMTCT in pregnancy period is 
advised.  
2. To evaluate preclinical and the clinical safety and efficacy of an HIV related drug (Faramir) SeyedAlinaghi et 
al., conducted a phase II clinical trial. Throughout the study, adherence to treatment, clinical observations, 
adverse effects, viral load and CD4 counts were constantly measured. Based on the results, although there 
was evidence supporting the efficacy and safety of Faramir, implementation of phase III clinical trial is 
recommended.  
3. To characterize factors affecting the acceptance or decline in HIV testing among Iranian patients, 
Bayanolhagh et al., conducted a cross sectional survey in three different health care centers on individuals 
unaware of their HIV status. Multiple factors were identified to have association with willingness to do HIV 
test; increasing knowledge about HIV testing, its availability, and keeping costs low can expand the desire to 
use the test and ultimately prevent the spread of HIV through lack of knowing one’s serostatus and lack of 
treatment. It is suggested to consider the Emergency departments in rural cities as target places to identify 
HIV infection at high-risk groups.  
4. To calculate the direct and indirect costs of HIV/AIDS, Hajiabdolbaghi et al., conducted a cross sectional 
study in the Voluntary Counseling and Testing (VCT) center of Imam Khomeini Hospital, 2010-2011. They 
have evaluated the cost in categories such as health-therapeutic, training, research, services and cost in 
total. According to the results of this study, the distribution of money spent on HIV/AIDS in the Imam 
Khomeini VCT center is relatively similar to low and middle income countries and training and research need 
more considerations.  
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